SCHEMBL16080104

SCHEMBL16080104

O=C1OC(c2ccccc2)=C/C1=C/c1cccs1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 14/20 1.00
KMT2A Q03164 9/20 1.00
MEN1 O00255 8/20 1.00
KDM4E B2RXH2 5/20 1.00
TDP1 Q9NUW8 2/20 1.00
ALDH1A1 P00352 11/20 0.52
HPGD P15428 5/20 0.52
RAB9A P51151 4/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
HTT P42858 3/20 0.52
NPC1 O15118 2/20 0.52
GAA P10253 1/20 0.52
PKM P14618 4/20 0.51
ALOX12 P18054 2/20 0.51
POLB P06746 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
HSD17B10 Q99714 1/20 0.51
LMNA P02545 1/20 0.50
NR1I2 O75469 1/20 0.40
MAPK1 P28482 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7599877 1.00 MAPT (1.00) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL7599882 1.00 MAPT (1.00) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL10577132 0.87 MAPT (0.77) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL10577130 0.87 MAPT (0.77) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL10577536 0.84 MAPT (0.74) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL10577532 0.84 MAPT (0.74) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL16080106 0.77 MAPT (0.62) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL28640889 0.75 MAPT (0.60) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL10575636 0.75 MAPT (0.59) MAPTKMT2AMEN1KDM4ETDP1
SCHEMBL10575626 0.75 MAPT (0.59) MAPTKMT2AMEN1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9812263-B2 Compound and photoelectric conversion device ADEKA CORPORATION (JP) 2017-11-07 US disclosed
US-9812263-B2 Compound and photoelectric conversion device ADEKA CORPORATION (JP) 2017-11-07 US disclosed
US-9805879-B2 Dye-sensitized solar cell ADEKA CORPORATION (JP) 2017-10-31 US disclosed
US-9805879-B2 Dye-sensitized solar cell ADEKA CORPORATION (JP) 2017-10-31 US disclosed
US-9530571-B2 Compound and support material supporting this novel compound ADEKA CORPORATION (JP) 2016-12-27 US disclosed
US-20160211085-A1 NOVEL COMPOUND AND PHOTOELECTRIC CONVERSION DEVICE ADEKA CORPORATION (JP) 2016-07-21 US disclosed
US-9324889-B2 Compound and photoelectric conversion device ADEKA CORPORATION (JP) 2016-04-26 US disclosed
US-20150380171-A1 CARRIER SYSTEM AND PHOTOELECTRIC CONVERSION DEVICE ADEKA CORPORATION (JP) 2015-12-31 US disclosed
US-20140299191-A1 DYE-SENSITIZED SOLAR CELL ADEKA CORPORATION (JP) 2014-10-09 US disclosed
US-20140261647-A1 NOVEL COMPOUND AND SUPPORT MATERIAL SUPPORTING THIS NOVEL COMPOUND ADEKA CORPORATION (JP) 2014-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160211085-A1 NOVEL COMPOUND AND PHOTOELECTRIC CONVERSION DEVICE CYP1B1, PAH, CRY1 MAPT 4548/4885KMT2A 1962/4885MEN1 1500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.